Price worries, bureaucratic obstacles, and “I’m-over-covid-itis” slow uptake of a drug that’s complicated to take but often effective.
Category: Kaiser Health News
Biden Said State of the Union Is Strong and Made Clear His Campaign Is Off and Running
President Joe Biden used his roughly 68-minute address to Congress to counter lackluster public approval ratings and draw clear contrasts between his administration’s policies and those of Donald Trump and some congressional Republicans. Abortion and health care were in the spotlight.
Biden Team, UnitedHealth Struggle to Restore Paralyzed Billing Systems After Cyberattack
The cyberattack on a unit of UnitedHealth Group’s Optum division is the worst on the health care industry in U.S. history, hospitals say. Providers struggling to get paid for care say the response by the insurer and the Biden administration has been inadequate.
California May Face More Than $40M in Fines for Lapses in Prison Suicide Prevention
A court expert reported that California prisons continue to lag on 14 of 15 suicide prevention measures, and even regressed in some areas. The state could face more than $40 million in fines after a federal judge warned more than a year ago that she would impose penalties for each violation.
VIP Health System for Top US Officials Risked Jeopardizing Care for Soldiers
The historically troubled White House Medical Unit is just one part of a government health system that gives VIP care to top officials, military officers, military retirees, and families. Pentagon investigators say some were prioritized over rank-and-file soldiers.
The State of the Union Is … Busy
At last, Congress is getting half of its annual spending bills across the finish line, albeit five months after the start of the fiscal year. Meanwhile, President Joe Biden delivers his annual State of the Union address, an over-the-counter birth control pill is (finally) available, and controversy erupts over new public health guidelines for covid-19 isolation. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Neera Tanden, the White House domestic policy adviser, about Biden’s health agenda. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
When It Comes to Ketamine, Meta’s Posting Policy Is No Party to Decipher
Despite growing awareness that the party drug is dangerous, the social media company is open to promotion of the drug in treating mental health.
Biden Is Right. The US Generally Pays Double That of Other Countries for Rx Drugs.
Research has consistently found that, overall, U.S. prescription drug prices are significantly higher, sometimes two to four times as high, compared with prices in other high-income industrialized countries. However, some market factors can obscure actual prices, making comparisons harder.
Why Even Public Health Experts Have Limited Insight Into Stopping Gun Violence in America
After the 1996 Dickey Amendment halted federal spending on research into firearms risks, a small group of academics pressed on, with little money or political support, to document the nation’s growing gun violence problem and start to understand what can be done to curb the public health crisis.
Whistleblower Accuses Aledade, Largest US Independent Primary Care Network, of Medicare Fraud
A recently unsealed lawsuit alleges Aledade Inc. developed billing software that boosted revenues by making patients appear sicker than they were.
